Vivos Therapeutics's market cap is currently $23.26M. The company's EPS TTM is $-0.55; its P/E ratio is ―; Vivos Therapeutics is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
